GSK-25
CAS No. 874119-56-9
GSK-25 ( —— )
产品货号. M17637 CAS No. 874119-56-9
GSK-25 maintains good selectivity against a panel of 31 kinases, as well as RSK1 and p70S6K (RSK1 IC50 of 398 nM, p70S6K IC50 of 1000nM), and a dramatically improved P450 profile (>2.2 uM at all isozymes tested).
纯度: 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥437 | 有现货 |
|
5MG | ¥680 | 有现货 |
|
10MG | ¥964 | 有现货 |
|
25MG | ¥1458 | 有现货 |
|
50MG | ¥2317 | 有现货 |
|
100MG | ¥3872 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称GSK-25
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述GSK-25 maintains good selectivity against a panel of 31 kinases, as well as RSK1 and p70S6K (RSK1 IC50 of 398 nM, p70S6K IC50 of 1000nM), and a dramatically improved P450 profile (>2.2 uM at all isozymes tested).
-
产品描述GSK-25 maintains good selectivity against a panel of 31 kinases, as well as RSK1 and p70S6K (RSK1 IC50 of 398 nM, p70S6K IC50 of 1000nM), and a dramatically improved P450 profile (>2.2 uM at all isozymes tested).
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体RSK1; mTOR (p70S6K)
-
研究领域——
-
适应症——
化学信息
-
CAS Number874119-56-9
-
分子量513.34
-
分子式C24H16Cl2F2N6O
-
纯度98%
-
溶解度——
-
SMILESClc1nccc(c1)C=2NC(C)=C(C(N=2)c3ccc(Cl)cc3F)C(=O)Nc4cc5cnnc5cc4F
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Sehon CA, et al. J Med Chem. 2008 Nov 13;51(21):6631-4.
产品手册
关联产品
-
CNS-5161 hydrochlori...
CNS-5161 hydrochloride is a new antagonist of NMDA ion-channel. It interacts with the NMDA receptor/ion channel site to produce a noncompetitive blockade of the actions of glutamate.
-
1-(3,4-dimethoxyphen...
1-(3,4-Dimethoxyphenyl)-2-(4-allly-2,6-dimethoxyphenoxy)propan-1-ol shows anti-staphylococcal activity against a total of five multidrug-resistant (MDR) and methicillin-resistant Staphylococcus aureus strains and the minimum inhibitory concentrations (MICs) are in the range of 128-256 ug/ml.
-
Mequitazine
Mequitazine is an effective, nonsedative and long-acting histamine H1 antagonist.